April 2026 HHVBP Interim Performance Reports Now Posted in iQIES

CMS releases updated HHVBP reports reflecting corrected 2025 risk adjustment processing and preview measures for the CY 2026 scoring transition.

CMS has released the Preliminary April 2026 Interim Performance Reports (IPRs) for the expanded Home Health Value-Based Purchasing (HHVBP) Model, including updated cohort assignments, measure-level data, and interim Total Performance Scores.

The reports incorporate corrected risk adjustment processing after CMS identified that CY 2025 OASIS-based episodes had been calculated using 2024 coefficients. Updated values now reflect the intended 2025 model, with CMS noting only small shifts in agency-level scores.

The release also continues CMS’s preview of the CY 2026 applicable measure set, including updated thresholds and benchmarks ahead of the October 2026 scoring transition.

Massachusetts home health agencies can use the April data to confirm measure eligibility, validate internal performance trends, and assess any operational impact from the corrected calculations.

Recalculation requests for the April Preliminary IPR are due May 15, 2026.

Continued monitoring of upcoming IPRs will support preparation for the first scoring cycle under the CY 2026 measure set later this year.

Action Steps Ahead of the CY 2026 Transition

• Review April IPR results for any unexpected shifts in OASIS-based measure performance.
• Confirm internal reports reflect 2025 risk adjustment coefficients when comparing values.
• Validate cohort assignment and measure eligibility for CY 2026 scoring.
• Determine whether a recalculation request is warranted before the May 15 deadline.
• Prepare for the October 2026 transition by tracking thresholds and benchmarks included in each new IPR.